Checkpoint Capital L.P. Portfolio Holdings

Checkpoint Capital L.P.

  • $202 Billion
  • Q3 2024

Checkpoint Capital L.P. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $202 Billion distributed in 16 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $50.1B, Rhythm Pharmaceuticals, Inc. with a value of $34.8B, Phathom Pharmaceuticals, Inc. with a value of $27.2B, Cytokinetics Inc with a value of $24.6B, and Axsome Therapeutics, Inc. with a value of $18.8B.

Examining the 13F form we can see an increase of $35.7B in the current position value, from $166B to 202B.

Checkpoint Capital L.P. is based out at San Francisco, CA

Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.

Portfolio value $202 Billion
Healthcare: $181 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$31.2B
$50.1 Billion 24.88% of portfolio
92,500
Q3 2024 Added 12.6%

Summary

  • Portfolio
  • No. of Stocks 16
  • Current Value $202 Billion
  • Prior Value $166 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 3 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Checkpoint Capital L.P. Portfolio

Follow Checkpoint Capital L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checkpoint Capital L.P., based on Form 13F filings with the SEC.

News

Stay updated on Checkpoint Capital L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email